Bal Pharma Ltd. benchmarking: Perfomance to industry peers

Financial

	Bal Pharma	Tyche Inds	Smruthi Organics
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	1.06 %	1.28 %	3.58 %
Financials
5 yr Average ROE	8.41 %	12.13 %	12.07 %
5yr average Equity Multiplier	4.51	1.16	1.54
5yr Average Asset Turnover Ratio	1.01	0.53	1.28
5yr Avg Net Profit Margin	1.86 %	19.18 %	6.02 %
Price to Book	1.49	0.8	2.03
P/E	17.1	11.66	30.77
5yr Avg Cash Conversion Cycle	27.6 Days	111.78 Days	70.37 Days
Inventory Days	99.82 Days	69.03 Days	63.4 Days
Days Receivable	115.65 Days	101.01 Days	105.63 Days
Days Payable	154.91 Days	90.14 Days	96.18 Days
5yr Average Interest Coverage Ratio	1.5	2385.83	10.52
5yr Avg ROCE	19.2 %	16.3 %	16.62 %
5yr Avg Operating Profit Margin	9.12 %	21.21 %	12.47 %
5 yr average Debt to Equity	1.95	0.0	0.14
5yr CAGR Net Profit	8.78 %	-9.09 %	-26.95 %
5yr Average Return on Assets	1.88 %	10.39 %	8.16 %
Shareholdings
Promoter Holding	50.86 %	61.97 %	64.73 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-1.14 %	0.0	1.22 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Bal Pharma	Tyche Inds	Smruthi Organics
Product Wise Break-Up	Product Wise Break-Up Formulations 52.96 Active Pharmaceutical Ingredient (API) 43.44 Manufacture of bulk drugs intermediates 0 0 Others 3.6	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 0 Bulk Chemicals 100.0 Formulations 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Bulk Chemicals 100.0 Manufacture of bulk drugs intermediates 0 Formulations 0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 60.58 India 36.5 International 0 Domestic 0 Others 2.92	Location Wise Break-Up International 47.91 India 0 Domestic 32.67 Rest of the World 0 Others 19.42	Location Wise Break-Up International 53.84 India 0 Domestic 46.16 Rest of the World 0